[DIV28SUPER] [GRAYMAIL] Joint NIH Council Meeting re: Functional Integration of NIDA, NIAAA and NCI - Dec. 13

 

Dear Colleagues,

 

There will be a Joint Meeting of the National Advisory Council on Alcohol Abuse and Alcoholism, the National Advisory Council on Drug Abuse, and the National Cancer Advisory Board on December 13, 2012, 11:30 a.m. – 1:00 p.m. ET.  Dr. Lawrence Tabak, Principal Deputy Director, National Institutes of Health (NIH), will provide an overview of the Trans-NIH Substance Use, Abuse, and Addiction Functional Integration Plan.  Please note, the public is welcome to join the call  1-888-324-8014 (toll-free); Passcode is 4418818

Webmeeting: http://webmeeting.nih.gov/suaa/.   Attached for your information is a copy of the open agenda. The public is also invited to submit additional comments to SUAAinfo@nih.gov through Friday, December 28, 2012.   Best regards,

 

 

Jane E. Smither
Constituent Liaison
Office of Science Policy and Communications
National Institute on Drug Abuse/NIH
6001 Executive Boulevard
Room 5230 MSC 9591
Bethesda, MD  20892-9591
Telephone - (301) 443-6071
Fax - (301) 443-6277
E-mail - jsmither@nida.nih.gov

www.drugabuse.gov

 

 

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

Bethesda, Maryland

AGENDA

Joint Meeting of the

National Advisory Council on Alcohol Abuse and Alcoholism, the National Advisory Council on Drug Abuse, and the National Cancer Advisory Board

December 13, 2012

11:30 a.m. to 1:00 p.m. ET

1-888-324-8014 (toll-free); Passcode is 4418818

Webmeeting: http://webmeeting.nih.gov/suaa/

Thursday, December 13, 2012 - OPEN

11:30 a.m. Call to Order

Lawrence A. Tabak, D.D.S., Ph.D., Principal Deputy Director, NIH

Review of Policy and Procedures

Justin D. Hentges, M.P.P., Special Assistant to the Principal Deputy Director, NIH

11:35 a.m. Overview of the Trans-NIH Substance Use, Abuse, and Addiction Integration Plan

Lawrence A. Tabak, D.D.S., Ph.D., Principal Deputy Director, NIH

12:05 p.m. Council Discussion

12:45 p.m. Public Comments*

1:00 p.m. Adjourn

*The public is invited to submit additional comments to SUAAinfo@nih.gov through Friday, December 28, 2012. The comments will be shared with the three Committees

 

 

 

You are receiving this message because you are part of The Association for the Treatment of Tobacco Use and Dependence (ATTUD) Listserv. To send a message to the entire listserv, send the email to ATTUD@LISTSRV.UCSF.EDU. To reply to a message to the entire listserv, please use "Reply All," and to respond individually to the email sender, use "Reply." This listserv is not moderated. Unless specifically stated, messages posted on this listserv represent only the views of the individuals posting the messages, and ATTUD does not endorse the accuracy of any "statements."

---

Use this link to unsubscribe from this mailing list.

[DIV28SUPER] OPERATION DELIRIUM

"...Decades after a risky Cold War experiment, a scientist lives with secrets.  ..."

http://www.newyorker.com/reporting/2012/12/17/121217fa_fact_khatchadourian?currentPage=all

This is a riveting story of army supported psychopharmacology at Edgewood Arsenal.  

 

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

[DIV28SUPER] [GRAYMAIL] NIH PA-13-018 Administrative Supplements for Research on Sex/Gender Differences (Admin Supp)

The NIH Office of Research on Women's Health (ORWH) and participating ICs including NIDA released on November 13 the  FOA, PA-13-018 Administrative Supplements for Research on Sex/Gender Differences (Admin Supp).  Supplements will be funded by an ORWH set aside.    The earliest submission date is December 12, 2012 and the application due date is January 11, 2013.

 

As is the case for all administrative supplements, research proposed under this announcement must be within the original scope of the parent grant.  Applicants should propose research that, if successful, would contribute to a greater understanding of the implications of sex/gender differences (or similarities) in human health or disease outcomes.   Applicants may use the following approaches to address sex/gender comparisons:

 

• The addition of another group of subjects (human or animal) of the opposite sex when subjects of only one sex were used in the original study for comparative analyses of sex/gender. Applicants proposing to use subjects of only one sex/gender will be considered non-responsive UNLESS the data will be compared with those from the opposite sex within the administrative supplement period;   
• The addition of more subjects  (human or animal) of both sexes to sufficiently power a study that was insufficiently powered to conduct or detect a sex/gender difference (or similarity) in the original study; or 
•  The analyses of preexisting data where sex-specific data are included and power is sufficient, but a sex/gender analysis was not performed as part of the original study.

 

TO UNSUBSCRIBE: send email to listserv@list.nih.gov<mailto:listserv@list.nih.gov>, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful.

If you have problems contact jpollock@mail.nih.gov     301-435-1309

The National Institute on Drug Abuse (NIDA)  at the National Institutes of Health is an agency of the United States Department of Health and Human Services 

[DIV28SUPER] APA Congressional Fellowship Porgram: online application open

Great opportunity- see below:

-----

Spend a year working on Capitol Hill

 

APA seeks applications for its Congressional Fellowship Program. This opportunity allows up to two psychologists to spend a year in Washington, D.C., where they receive first-hand experience with federal policymaking. Congressional Fellows work as special legislative assistants in congressional member or committee offices and engage in a diverse range of policymaking activities.  APA offers specialized Congressional Fellowships for midcareer professionals, experts in health and behavior issues, and developmental psychologists and clinicians with experience working with children.  The program offers a year-long stipend and funds to support relocation, travel, and the purchase of health insurance. For more information, visit http://www.apa.org/about/gr/fellows or call the Public Interest Government Relations Office at 202.336.5935.

 

Applications must be postmarked by Jan. 11, 2013.

--
Kelly Dunn, Ph.D.
Instructor
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
BPRU Phone: (410) 550-2254
CLH Phone: (410) 550-5370
Fax: (410) 550-0030
 
WARNING:  E-mail sent over the Internet is not secure.  Information sent by e-mail may not remain confidential.
DISCLAIMER:  This e-mail is intended only for the individual to whom it is addressed.  It may be used only in accordance with applicable laws.  If you received this e-mail by mistake, notify the sender and destroy the e-mail

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

[DIV28M] Call for papers for Special Issue of Experimental and Clinical Psychopharmacology

Experimental and Clinical Psychopharmacology will publish a Special Issue focused on Psychopharmacology of Attention: The Impact of Drugs in an Age of Increased Distractions in October 2013.  The goal of this special issue is to highlight progress made during the past 15 years in understanding how licit and illicit drugs impact attention within the context of prevailing contemporary distractions. Topics such as distracted driving, social networking, animal and human models of multitasking, and attention-deficit/hyperactivity disorder are just a few of the areas of relevance to this special issue.   

Laboratories engaged in research in this area may submit review articles or primary research reports to Experimental and Clinical Psychopharmacology to be considered for inclusion in this Special Issue. Please contact the Guest Editor, Dr. Anthony Liguori, or the Editor, Dr. Suzette Evans, directly (see below) with your topic, a draft title and a draft abstract before submitting your manuscript.  These will also us to create a dynamic and diverse issue on these topics.  Manuscripts should be submitted as usual through the APA Online Submission Portal, and the cover letter should indicate that the authors wish the manuscript to be considered for publication in the Special Issue on Psychopharmacology of Attention. While we cannot guarantee that your submission will be accepted for inclusion in the final published special section, we hope that you will consider submitting a manuscript for this Special Issue. Manuscripts received no later than February 15, 2013 will be considered for inclusion in the Special Issue. 

Questions or inquiries about the Special Issue can be directed to the Guest Editor of the issue, Anthony Liguori, Ph.D., at aliguori@wakehealth.edu or the Editor, Suzette M. Evans, Ph.D., at se18@columbia.edu.

Suzette M. Evans, Ph.D.

Professor of Clinical Neuroscience and Research Scientist VI

Director of the Women's Research Center

Editor, Experimental and Clinical Psychopharmacology

Columbia University and the New York State Psychiatric Institute

1051 Riverside Drive

Unit 66, Room 3704

New York NY 10032

Voice: 212-543-5895

Fax: 212-543-6018

IMPORTANT NOTICE: This e-mail is meant only for the use of the intended

recipient. It may contain confidential information that is legally privileged

or otherwise protected by law. If you received this e-mail in error or from

someone who was not authorized to send it to you, you are strictly prohibited

from reviewing, using, disseminating, distributing or copying the e-mail. PLEASE

NOTIFY US IMMEDIATELY OF THE ERROR BY RETURN E-MAIL AND DELETE THIS MESSAGE FROM YOUR SYSTEM. Thank you for your cooperation.

[DIV28M] APA Division 28 Awards 2013

Dear Colleagues:  Please find attached the Call for Nominations for the Division 28 APA awards for the upcoming 2013 meeting in Honolulu, Hawaii.  Feel free to share this announcement with others and post in your departments.  We look forward to receiving your nominations!

--

Dr. Sharon L. Walsh

Center on Drug and Alcohol Research

Department of Behavioral Science

Phone:  859-257-6485

Fax: 859-257-5232

email:  sharon.walsh@uky.edu

[DIV28_ANNOUNCEMENT] Collaborative Perspectives on Addiction - Deadline Extended!

The Planning Committee for the first-ever Division 28/50 Annual Conference recognizes that the holiday season is a

busy one and has extended the deadline for Breakout Sessions to December 15, 2012. Please take a moment to consider

submitting a proposal AND please forward to colleagues to do the same. Presenting in the same program along with Dr. Shiffman

and Dr. Sullivan is quite an hour, and so will be presenting at the INAUGURAL conference! Don’t miss out!

 

 

 

Call for Proposals - Deadline– EXTENDED! APA Division 28 and Division 50 invite you to submit a proposal for a Breakout Session or Poster Presentation at their first annual conference. Proposals that fit within the theme of "Biobehavioral RESEARCH & Implications for PRACTICE" will be considered for this first-annual endeavor. Breakout Session: December 15 deadline, submit at www.tinyurl.com/2013CPABreakout Poster Deadline: February 1 deadline, submit at www.tinyurl.com/2013CPAPoster The official Call for Proposals is attached. The program committee (listed below) is available to answer any questions you have.   About the Conference   The theme for the 2013 conference is "Biobehavioral RESEARCH & Implications for PRACTICE" >>Atlanta, Georgia / May 3-4, 2013 >>Registration will open December 2012 >>Two thought-provoking keynote sessions >>Interactive environment for collaboration/networking >>Several breakout session choices >>Poster Sessions >>Pre-conference in-depth workshops >>Discounted rates for Early Career Psychologists >>Student opportunities (discounted rates, special networking, etc) >>You don't have to be a member of either or division or APA to attend the conference! Meet the Keynoters   Saul Shiffman, PhD, is a world-renowned researcher in the fields of behavior change and relapse, self-management and self-control, field research methodology, statistical analysis, and addiction and dependence. Since 1991, he has been a professor in the departments of psychology and pharmaceutical science at the University of Pittsburgh. Dr. Shiffman has taught in the departments of psychology and psychiatry and behavioral medicine at various universities, including the University of South Florida, the University of Washington, and the University of Pittsburgh. Dr. Shiffman has authored or co-authored over 300 published papers on a variety of topics related to psychopharmacology, substance abuse, dependence, relapse, coping, and computerized assessments of behavior, and has presented widely in medical and scientific forums. A fellow of numerous professional societies (including APA Divisions 28 and 50), Dr. Shiffman was awarded the Society for Research on Nicotine and Tobacco’s Ovid Ferno Award for “ground breaking advances in clinical research.”   Edith V. Sullivan, PhD, is professor of psychiatry and behavioral sciences at Stanford University School of Medicine and a neuropsychologist who has pioneered the study of alcoholism-related brain injury on selective cognitive and motor function. She is the recipient of a Senior Scientist Research and Mentorship Award, a grant for international collaborations on alcoholism research, and an NIAAA MERIT award for studies of neural circuitry modification in alcoholism focused on frontocerebellar systems. Dr. Sullivan is a recipient of the Research Society on Alcoholism Distinguished Researcher Award and is author of more than 250 peer-reviewed papers and numerous chapters and reviews. Dr. Sullivan will present a keynote address on Saturday, May 4, titled “Alcoholism and the Brain: Road to Ruin and Path to Recovery.” Call for Proposals   The Committee has issued a call for proposals for Breakout Sessions, and Posters. Deadlines are as follows: Breakout Sessions: December 1, 2012 Posters: February 1, 2013 About the Venue   The beautiful W Hotel in Midtown Atlanta will be the venue for our First Annual Conference. The hotel is located in the heart of Midtown and is local to public transportation. Room rates are $159 per night. Hotel reservation information will be launched soon! More Information?   Sara Jo Nixon, PhD, Conference Chair Anthony Liguori, PhD, Conference Co-Chair John Kelly, PhD, Sponsorship Co-Chair Katie Witkiewitz, PhD, Sponsorship Co-Chair Jennifer Buckman, PhD, Conference Treasurer Chad Rummel, MEd, Registration and Hotel Accommodations (202-336-6121)